The BRCA1insC mutation results in the expression of a truncated BRCA1 missing the C-terminal BRCT repeat that interacts with phosphopeptides and promotes HR, which is necessary for tumor suppression (56). This evidence concerns the gene BRCA1 and neoplasm.